Concise synthesis of the anti-HIV nucleoside EFdA

Biosci Biotechnol Biochem. 2012;76(6):1219-25. doi: 10.1271/bbb.120134. Epub 2012 Jun 7.

Abstract

EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine), a nucleoside reverse transcriptase inhibitor with extremely potent anti-HIV activity, was concisely synthesized from (R)-glyceraldehyde acetonide in an 18% overall yield by a 12-step sequence involving highly diastereoselective ethynylation of an α-alkoxy ketone intermediate. The present synthesis is superior, both in overall yield and in the number of steps, to the previous one which required 18 steps from an expensive starting material and resulted in a modest overall yield of 2.5%.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemical synthesis*
  • Deoxyadenosines / chemical synthesis*
  • Glyceraldehyde / analogs & derivatives*
  • Glyceraldehyde / chemistry
  • HIV / enzymology
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • HIV Reverse Transcriptase / chemistry
  • Humans
  • Magnetic Resonance Spectroscopy
  • Reverse Transcriptase Inhibitors / chemical synthesis*
  • Stereoisomerism

Substances

  • Anti-HIV Agents
  • Deoxyadenosines
  • Reverse Transcriptase Inhibitors
  • glyceraldehyde acetonide
  • Glyceraldehyde
  • HIV Reverse Transcriptase
  • islatravir